Vincent Picozzi, MD

GI Oncology Now

Vincent Picozzi, MD, Virginia Mason Medical Center, talks about the PANOVA-3 phase 3 clinical trial that examined the use of tumor treating fields (TTFields) with gemcitabine and nab-paclitaxel for the treatment of locally advanced pancreatic adenocarcinoma.
Dr. Picozzi highlights how the PANOVA-3 trial is the first phase 3 trial to demonstrate a statistically significant overall survival benefit in patients, what that means for pancreatic cancer research, and more.

Vincent Picozzi, MD, Virginia Mason Medical Center, talks about the PANOVA-3 phase 3 clinical trial that examined the use of tumor treating fields (TTFields) with gemcitabine and nab-paclitaxel for the treatment of locally advanced pancreatic adenocarcinoma.Dr. Picozzi highlights how the PANOVA-3 trial is the first phase 3 trial to demonstrate a statistically significant overall survival benefit in patients, what that means for pancreatic cancer research, and more.

Emily Menendez

Radiotherapy With Sintilimab, Capecitabine, Oxaliplatin Effective as Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer

Colorectal Cancer

Despina Siolas, MD, PhD

Dr. Despina Siolas: The Value of Mentorship and Resilience in GI Oncology Research

Pancreatic Cancer

Jessica Ganga

Assessing Total Neoadjuvant Therapy Regimens for Rectal Cancer: Is There a Consensus Among Physicians?

Latest News

Tumor-Treating Fields Combined With Gemcitabine and Nab-Paclitaxel for Locally Advanced Pancreatic Cancer: PANOVA-3 Trial

Dr. Picozzi details PANOVA-3, where TTFields with chemo showed significant survival gains in advanced pancreatic cancer.

PANOVA-3: TTFields Combined With Chemotherapy for LA-PAC

About Us

Editorial Policy

Advertising

eNewsletters

Contribute

GU Oncology Now

Lung Cancers Today

Cancer Nursing Today

DocWire News

MashupMD

Bile Duct

Colorectal

Esophageal

Gastric

GEP-NETs

GIST

Liver

Pancreatic

Conference Coverage

Video Insights

Roundtable